[1] |
ZHANG Jinghui, WEI Haoliang, WANG Li, LI Jingkai, ZHANG Baolai, YANG Xiaolai.
Effects of AMI-1 on the activity of pancreatic cancer cells in vitro by down-regulating PRMT5 expression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 601-608.
|
[2] |
ZHANG Huabin, LUO Zhongxu, ZHONG Min, HONG Zongyuan, WANG Deguo.
Study on the effect of spinal anesthesia on ventricular arrhythmias in acute myocardial ischemia-reperfusion in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 249-256.
|
[3] |
HE Xudong, FU Zhongyu, HUANG Ying, HE Jinbiao, PU Xuemei, LI Jie, LI Yanjuan, YU Jie, YANG Xingxin.
Research progress on chemistry and bioactivity of isopentenyl flavonoids from Sophora flavescens
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 899-907.
|
[4] |
XU Hui, YANG Xinyu, ZHAO Zhehui, WANG Yan.
Research progress and thinking on the metabolism of polysaccharide drugs in vivo and the key technology of PK/PD
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 851-862.
|
[5] |
JIANG Jianbo, SUN Qian, DING Fengfei.
Interstitial ions regulate sleep and wakefulness
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 794-801.
|
[6] |
JING Yongshuai, ZHANG Yuwei, WU Lanfang, ZHANG Ruijuan, MA Yunfeng, ZHANG Danshen.
Research progress on extraction methods and pharmacological activities of polysaccharide from traditional Chinese herb compound
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 462-468.
|
[7] |
WANG Limin, FANG Bin, FANG Haixiao, BAI Hua, LI Lin.
Application of MAO-A/B subtype activity detection in diagnosis and treatment of neurological diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1052-1058.
|
[8] |
LIU Weiyi, SUN Jianguo, CAO Weiling, WANG Guangji, WANG Hong.
Advances in farnesoid X receptor antagonists and their pharmacological activities
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 764-774.
|
[9] |
ZHANG Yu, PENG Ying, WANG Guangji, SUN Jianguo.
Advances in study of phase II metabolic enzyme expression and activity under diseases status
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 686-700.
|
[10] |
ZHANG Haowen, ZHU Yejin, WU Xiang, CHEN Hanyu, SONG Yulei, BIAN Yaoyao, HAO Haiping, CHEN Xiaohu.
Study on high on-aspirin platelet reactivity in diabetic mice based on metabonomics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(3): 246-256.
|
[11] |
LIN Zhong, XIE Qunli, LI Shengying, JIN Hui, XU Fenfen, XIE Liyun, JIANG Zhengli.
Advanced of HER-2/neu epitope anti-tumor vaccine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1046-1052.
|
[12] |
BAO Jing,LI Xiaofeng,ZHANG Hanshuo,XU Qingqing,MENG Xiaoming,HUANG Cheng,LI Jun.
Role of RAB32 on proliferation and migration of chronic myeloid leukemia K562 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(12): 1321-1327.
|
[13] |
GUO Li, HAN Chenyang.
Preparation of piperine liposomes and its antitumor activity of gastric cancer cells in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1240-1245.
|
[14] |
ZENG Xiangchang, ZHOU Luping, CHEN Lulu, LUO Wei, LI Chaopeng, GAO Qing, WANG Yaqin, WANG Xintong, HU Kai, SHEN Jie, OUYANG Dongsheng.
Effects of ginsenoside C-K on seizure activity in pilocarpine-induced epileptic rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(2): 139-143.
|
[15] |
MA Xiao-qin, XIN Hua-wen, LI Yuan-qi, HUANG Hui, ZHAO Li, YU Ai-rong, LI Wei-liang, WU Xiao-chun.
Association of HGPRT activity and gene polymorphism with adverse reactions caused by azathioprine in kidney transplant recipients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(2): 182-187.
|